19 Dec 2023

BIA response to NICE TA-HST charging review

The BIA has responded to NICE's consultation on changes to charging for Technology Appraisals  (TA) and the Highly Specialised Technology (HST) programme.

The response calls on NICE to provide greater transparency in the justification for the proposed increase in charges, and to demonstrate increased value to companies for the higher fees by delivering continual improvements to its processes, including by:

  • Publishing more data on NICE processes, creating more transprency and accountability. 
  • Introducing 'after-action reviews' after each appraisal with all participants represented.
  • Making changes to committee meetings to make them less adversarial for patients and clinicians.
  • Developing success criteria to review the performance of External Assessment Groups (EAGs) in appraisals. 
×
deep biotech.png

Welcome to the new BIA site!

BIA are excited to announce the soft launch of our new website!

Our team is diligently working behind the scenes to enhance your browsing experience and provide you with valuable content. During this phase, you may encounter sections that are still under construction. We kindly ask for your patience as we finalise everything.

Thank you for visiting, and we thank you for your continuous support towards BIA.